Article info
Respiratory research
Original research
Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier
- Correspondence to Professor Jung Soo Suk, Center for Nanomedicine, Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, USA; jsuk{at}jhmi.edu
Citation
Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier
Publication history
- Received June 4, 2020
- Accepted August 27, 2021
- First published October 25, 2021.
Online issue publication
July 25, 2022
Article Versions
- Previous version (25 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.